logo munafa.org.in

NEWS Gainers Losers
 Learn then Earn

 story : Pfizer to pay at least billion to develop, commercialize Arvinas' investigational breast-cancer therapy #FinanceUSA #StockMarketNEWS Shares of Arvinas Inc. were up 6.0% in premarket trading on

@stockMarketNEWS 9 Days ago

Posted in: #FinanceUSA #StockMarketNEWS

Pfizer to pay at least billion to develop, commercialize Arvinas' investigational breast-cancer therapy #FinanceUSA #StockMarketNEWS
Shares of Arvinas Inc. were up 6.0% in premarket trading on Thursday after the company announced a billion-dollar deal with Pfizer Inc. to develop and commercialize its experimental breast-cancer treatment. Pfizer will make a 0 million upfront payment to Arvinas, in addition to a 0 million equity investment. Separately, there are up to .4 billion in potential milestone payments. The therapy, ARV-471, is expected to move into Phase 3 clinical trials sometime next year. Arvinas' stock is down 8.7% for the year, while the S&P 500 is up 15.1%.


Munafa USA Munafa India Munafa NSE


Report

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

 Learn then Earn
Back to top | Use Dark Theme